0001104659-24-028281.txt : 20240227
0001104659-24-028281.hdr.sgml : 20240227
20240227170434
ACCESSION NUMBER: 0001104659-24-028281
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240223
FILED AS OF DATE: 20240227
DATE AS OF CHANGE: 20240227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NEWHALL CHARLES W III
CENTRAL INDEX KEY: 0001005544
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 24688194
MAIL ADDRESS:
STREET 1: 1119 ST PAUL ST
CITY: BALTIMORE
STATE: MD
ZIP: 21202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060317
4
1
tm247055-15_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-23
0
0001356576
SUPERNUS PHARMACEUTICALS, INC.
SUPN
0001005544
NEWHALL CHARLES W III
C/O SUPERNUS PHARMACEUTICALS, INC.,
9715 KEY WEST AVENUE
ROCKVILLE
MD
20850
1
0
0
0
0
Common Stock
2024-02-23
4
A
0
3886
0
A
120975
D
Restricted Stock Unit
2024-02-23
4
D
0
3886
0
D
Common Stock
3886
0
D
Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024.
/s/ Timothy C. Dec, as attorney-in-fact
2024-02-27